The first panel was designed to identify cytokeratin+ (CK+) tumor/epithelial cells, CD3+ T cells, CD3+Foxp3+ regulatory T cells (Tregs), CD20+ B cells, and CD117+CK− mast cells (Figure 2A). The gene discussed is KIT; the disease is neoplasm.